https://health.economictimes.indiatimes.com/news/pharma/financial-performance/natco-pharma-q1-profit-up-59-pc-at-rs-668-cr/112471603
Natco Pharma Q1 profit up 59 pc at Rs 668 cr, ETHealthworld
Revenue from operations rose to Rs 1,363 crore from Rs 1,140 crore in the year-ago period, Natco Pharma said in a regulatory filing.
natco pharma
https://health.economictimes.indiatimes.com/news/pharma/taiho-pharmaceuticals-moves-us-court-against-natco-on-generic-cancer-drug/73070766
Natco Pharma: Taiho Pharmaceuticals moves US court against Natco on generic cancer drug,...
Natco Pharma: In a petition filed in the United States District Court for the District Court of Delawareon December 30, Taiho alleged that the Indian drug...
natco pharma
https://pharma.economictimes.indiatimes.com/tag/natco+pharma
Natco pharma - Latest natco pharma , Information & Updates - Pharma -ETPharma
ETPharma.com brings latest natco pharma news, views and updates from all top sources for the Indian Pharma industry.
natco pharmalatest informationupdates
https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/natco-pharma-gets-warning-letter-from-usfda-for-telangana-plant/109156043
Natco Pharma gets warning letter from USFDA for Telangana plant, ETHealthworld
Natco Pharma on Tuesday said it has received a warning letter from the US health regulator for its Telangana-based manufacturing plant. The US Food and Drug...
natco pharmawarning lettergets
https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/natco-pharma-submits-abbreviated-new-drug-application-with-usfda-for-generic-cancer-drug/112903460
Natco Pharma submits abbreviated new drug application with USFDA for generic cancer drug,...
Generic Cancer Drug: The drug firm believes it is the first company to have filed a substantially-complete ANDA containing a Paragraph IV Certification for...
new drug applicationnatco pharma
https://health.economictimes.indiatimes.com/news/pharma/natco-pharma-submits-application-with-usfda-for-generic-cancer-drug/97864131
Kudos Pharmaceuticals: Natco Pharma submits application with USFDA for generic cancer drug,...
Kudos Pharmaceuticals: The company has submitted an Abbreviated New Drug Application (ANDA) containing a 'paragraph IV' certification with the US Food and Drug...
natco pharma
https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/usfda-pulls-up-natco-pharma-for-manufacturing-lapses-at-telangana-plant/109472621
USFDA pulls up Natco Pharma for manufacturing lapses at Telangana plant, ETHealthworld
Manufacturing Lapses: The USFDA sought a comprehensive, independent assessment of your overall system for investigating deviations, discrepancies, complaints,...
natco pharmafor manufacturing
https://pharma.economictimes.indiatimes.com/news/financial-performance/natco-pharma-q3-results-profit-declines-37-to-rs-132-crore/118204413
NATCO Pharma Q3 Results: Profit declines 37% to Rs 132 crore, ETPharma
Fiscal Year: Consolidated revenue from operations in the quarter under review stood at Rs 474.8 crore as compared to Rs 758.6 crore in the same period a year...
natco pharma
https://pharma.economictimes.indiatimes.com/tag/natco+pharma+shares
Natco pharma shares - Latest natco pharma shares , Information & Updates - Pharma -ETPharma
ETPharma.com brings latest natco pharma shares news, views and updates from all top sources for the Indian Pharma industry.
natco pharmalatest informationsharesupdates
https://health.economictimes.indiatimes.com/news/pharma/natco-pharma-proposes-to-acquire-dash-pharmaceuticals/88280226
Natco Pharma proposes to acquire Dash Pharmaceuticals, ETHealthworld
This acquisition provides Natco with a front-end to engage with its customers directly in the USA which is the largest pharmaceutical market in the world.
natco pharmaproposesacquiredashpharmaceuticals
https://privateinvestor.substack.com/p/natco-pharma-chasing-optionalities/comments
Comments - Natco Pharma: Chasing Optionalities
Business Playbook, History of Several Feats, Astute Management and The Revlimid Opportunity
natco pharmacommentschasing
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/usfda-makes-6-observations-at-natco-pharmas-kothur-facility/articleshow/56773975.cms
Natco Pharma: USFDA makes 6 observations at Natco Pharma's Kothur facility
Natco Pharma said it will provide due justifications and corrective action plan within next 15 working days to the address the USFDA observations.
natco pharmausfdamakesobservationskothur
https://health.economictimes.indiatimes.com/news/pharma/natco-pharma-gets-green-nod-for-rs-480-crore-expansion-project/58780229
Natco Pharma gets green nod for Rs 480 crore expansion project, ETHealthworld
Natco Pharma has received environment clearance (EC) for its Rs 480 crore expansion project in Telangana that would generate 1,500 jobs.
natco pharma
https://www.business-standard.com/amp/markets/capital-market-news/natco-pharma-submits-anda-with-us-fda-for-risdiplam-124112100654_1.html
Natco Pharma submits ANDA with US FDA for Risdiplam | Capital Market News - Business Standard
Natco Pharma informed that it has submitted the abbreviated new drug application (ANDA) with the United States Food and Drug Administration (USFDA) for...
https://health.economictimes.indiatimes.com/news/pharma/natco-pharma-q1-net-profit-rise-multifold-to-rs-320-4-cr/93454170
Natco Pharma Q1 net profit rise multifold to Rs 320.4 cr, ETHealthworld
The pharmaceutical segment revenue increased to Rs 883.6 crore from Rs 409.7 crore in the first quarter of last year. This was inclusive of an income from the...
https://www.business-standard.com/amp/markets/news/here-s-why-natco-pharma-share-price-gained-over-4-on-october-7-details-124100700331_1.html
Here's why Natco Pharma share price gained over 4% on October 7; details | News on Markets -...